Search results
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 4 days agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
Mom suffers ‘disabling pain’ after COVID shot trial, suit says. She’s suing AstraZeneca
Miami Herald via Yahoo News· 3 days agoA Utah mother is suing AstraZeneca after she participated in a clinical trial for the company’s ...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 4 days agos (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the license deal with Sanofi (SNY). The deal signed with Sanofi on May 10, 2024, relates ...
Opinion | Trump’s vaccine campaign pledge is worse than it sounds
MSNBC via Yahoo News· 2 days agoDonald Trump’s rally speeches have slammed vaccine mandates, and not just for Covid. What if Measles...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British ...
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 4 days agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
Despite its 'nothingburger' reputation, COVID-19 remains deadlier than the flu
Los Angeles Times· 2 days agoPeople hospitalized in 2020 with the then-novel respiratory disease were five times more likely to...
Three specific groups issued urgent warning as UK Covid cases on the rise
Daily Express· 5 days agoHealth bosses have issued a warning to three groups of people amid a rise in cases of COVID-19 in...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 5 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
One of the most shorted stocks on the market just leapt 99%, putting a ‘rib-crunching’ squeeze on...
Fortune· 7 days agoShares of the vaccine maker soared 99% Friday, after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid ...